Analysts Expect Henry Schein, Inc. (NASDAQ:HSIC) Will Announce Quarterly Sales of $2.93 Billion

Equities analysts expect Henry Schein, Inc. (NASDAQ:HSIC) to announce sales of $2.93 billion for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Henry Schein’s earnings, with estimates ranging from $2.83 billion to $3.01 billion. Henry Schein posted sales of $2.84 billion in the same quarter last year, which would indicate a positive year over year growth rate of 3.2%. The business is expected to announce its next earnings results on Monday, November 1st.

According to Zacks, analysts expect that Henry Schein will report full year sales of $11.94 billion for the current fiscal year, with estimates ranging from $11.64 billion to $12.18 billion. For the next fiscal year, analysts forecast that the firm will post sales of $12.34 billion, with estimates ranging from $11.89 billion to $12.95 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Henry Schein.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 3rd. The company reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.98 by $0.13. The company had revenue of $2.97 billion during the quarter, compared to the consensus estimate of $2.87 billion. Henry Schein had a return on equity of 15.86% and a net margin of 5.09%. The firm’s revenue for the quarter was up 76.2% on a year-over-year basis.

HSIC has been the subject of several recent analyst reports. Barrington Research upped their price target on Henry Schein from $91.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 4th. Piper Sandler upped their price target on Henry Schein from $89.00 to $95.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 3rd. Finally, TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Tuesday, May 18th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $89.25.

Large investors have recently added to or reduced their stakes in the stock. Parametric Portfolio Associates LLC increased its stake in Henry Schein by 3.0% in the second quarter. Parametric Portfolio Associates LLC now owns 431,320 shares of the company’s stock worth $32,000,000 after purchasing an additional 12,654 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in Henry Schein in the second quarter worth $701,000. Marshall Wace LLP increased its stake in Henry Schein by 2.4% in the second quarter. Marshall Wace LLP now owns 104,241 shares of the company’s stock worth $7,734,000 after purchasing an additional 2,463 shares during the period. Boston Common Asset Management LLC grew its position in shares of Henry Schein by 111.8% during the 2nd quarter. Boston Common Asset Management LLC now owns 106,460 shares of the company’s stock worth $7,898,000 after buying an additional 56,185 shares in the last quarter. Finally, Wells Fargo & Company MN grew its position in shares of Henry Schein by 5.4% during the 2nd quarter. Wells Fargo & Company MN now owns 675,697 shares of the company’s stock worth $50,130,000 after buying an additional 34,374 shares in the last quarter. Institutional investors own 93.16% of the company’s stock.

Shares of NASDAQ:HSIC traded up $0.73 during mid-day trading on Tuesday, reaching $78.44. 624,707 shares of the company traded hands, compared to its average volume of 907,888. The company’s 50 day moving average price is $76.93 and its 200-day moving average price is $74.39. The firm has a market cap of $10.96 billion, a PE ratio of 18.46, a PEG ratio of 1.32 and a beta of 0.88. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.79 and a quick ratio of 0.98. Henry Schein has a 52 week low of $56.31 and a 52 week high of $83.45.

Henry Schein Company Profile

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Further Reading: Liquidity

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.